Three-dose course of the hepatitis B vaccine fully protects adults living with HIV : vimarsana.com

A three-dose course of the hepatitis B vaccine HEPLISAV-B fully protected adults living with HIV who had never been vaccinated against or infected with the hepatitis B virus (HBV), according to study findings presented today at the IDWeek conference in Washington, D.C.

Related Keywords

New York , United States , South Africa , California , Emeryville , Thailand , Washington , Kennethe Sherman , Emily Henderson , Centers For Disease , National Institute Of Allergy , National Institutes Of Health , Dynavax Technologies Corp , Lab Diagnostics Automation , Drug Administration , Lab Diagnostics Automation Industry , University Of Cincinnati College Medicine , Weill Cornell Medical College , National Institute , Infectious Diseases , National Institutes , Disease Control , Dynavax Technologies , Automation Industry Focus , Cincinnati College , Kristen Marks , New York City , Hepatitis , Epatitis B , Iv , Accine , Ids , Llergy , Antiretroviral , Hronic , Bv , Hepatitisb Virus , Nfectious Diseases , Iver , Iver Disease , Edical Research , Mh , Esearch , Irus ,